Shefali Agarwal

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.4K citations · Full text

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos et al. · The Lancet Oncology · 2020 · 556 citations · Full text

Lymphoid Neoplasia, Oncology, Malignant Blood Disorder +7

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones et al. · The Lancet Oncology · 2020 · 383 citations

Tumor Biology, Medicine, Basket Study +8

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial

J. Berth‐Jones, Anita Takwale, E.Z.Z. Tan et al. · British Journal of Dermatology · 2002 · 258 citations

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Amit M. Oza, Ursula A. Matulonis, Susanne Malander et al. · The Lancet Oncology · 2018 · 123 citations

Medicine, Cancer Management, Gynecology +7